Time for a new IMU thread!, page-11

Here are two more valid theories for Alzheimer’s. The video is really interesting and the drug mentioned is in Ph2 trials and now available for compassionate use.

https://articles.mercola.com/sites/...treating-mercury-toxicity-with-emeramide.aspx

The second one is and oldie from 1977 but still valid . Alzheimer’s is really complex, like CVD which also won’t be cured by a single drug or approach. Both have heavy metals as a major factor.

https://n.neurology.org/content/27/3/213


This all highlights why IMU is such a good opportunity. Cancer is multifactorial as well, but targeted precision medicine can block the process. And it appears from results released so far B Cell therapy can stop it in its tracks for some patients. Having such a strong proof of concept and such a huge addressable market really does make this a great opportunity.

When the Market Cap is IMU is taken into consideration, it’s a really good risk management strategy to have IMU in your portfolio. If successful the returns on a small investment will produce outsized returns for risk taken.